3Gulgun M,Balci E,Karaoglu A,et al.Prevalence and risk factors of onychomycosis in primary school children living in rural and ur- ban areas in central anatolia of turkey[J].Indian J Dermatol Vene- reol Leprol,2013,79(6):777-782.
5Ghelardi E,Celandroni F,Gueye SA,et al.Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum[J].Antimicrob Agents Chemother,2014,58(5):2825-2829.
7Liu T,Xu Xt Leng W,et al.Analysis of gene expression changes in Trichophyton rubrum after skin interaction[J].J Med Microbi- ol,2014,63(Pt 5):642-648.
6Romani L.Immunity to fungal infections.Nat Rev Immunol 2004;4(1):1-23.
7Trinchirei G.Interleukin-12 and the regulation of innate resistance and adaptive immunity.Nat Rev Immunol 2003;3(2):133-146.
8Jennings MB, Weinberg JM, Koestenblatt EK, et al. Study of clinically suspected onychomycosis in a podiatric population[J].J Am Podiatr Med Assoc, 2002, 92(6): 327-30.
9van de Veerdonk FL, Kullberg B J, van der Meer JW, et al. Host-microbe interactions: innate pattern recognition of fungal pathogens[J]. Curt Opin Microbiol, 2008,11 (4): 305-12.
10Ferwerda B, Ferwerda G, Plantinga TS, et al. Human dectin-1 deficiency and mucocutaneous fimgal infections[J]. N Engl J Med, 2009, 361(18): 1760-7.
